SUBSCRIBE
SUBSCRIBE
Biotech Bay

Anemia Drugs Help End-Stage Anemic Kidney Patients, Stanford University School of Medicine Study

March 3, 2010 | 
1 min read

CHICAGO (Reuters) - Aggressive treatment with blockbuster anemia drugs may offer the best approach for kidney dialysis patients with severe anemia, U.S. researchers said on Tuesday.

MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: 3D image of a KRAS oncogene
Business
BridgeBio Spins Out Oncology Company with $200M in Financing
May 2, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: Bristol Myers Squibb office in California
Biotech Bay
BMS Taps Cellares in $380M CAR T Cell Therapy Manufacturing Agreement
April 22, 2024
 · 
2 min read
 · 
Tyler Patchen